PPG, Essilor in talks about Transitions Optical joint venture

Article

Discussions continue about what the future will hold for the Transitions Optical, the joint venture of Essilor International and PPG Industries.

 

Pittsburgh-PPG Industries Inc. continues discussions with Essilor International regarding the future of PPG’s and Essilor’s joint venture (JV), Transitions Optical. PPG is majority shareholder in Transitions Optical, holding a 51% interest in the JV companies. Essilor holds the remaining 49% interest and also is the largest customer of Transitions Optical.

PPG said it cannot predict the outcome of the discussions with Essilor regarding the future of Transitions Optical but believes that possible outcomes may include a modification of the current JV structure, a sale of all or a portion of PPG’s interests in Transitions Optical to Essilor, or a sale of all or a portion of Essilor’s interests in Transitions Optical to PPG.

PPG said it cannot predict the timing of the completion of its discussions with Essilor but expects that these talks are likely to continue over the next several months.

The two shareholders emphasized that their discussions will not impact the day-to-day operations of Transitions Optical. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.